SI-BONE Stock (NASDAQ:SIBN)
Previous Close
$15.49
52W Range
$11.70 - $20.05
50D Avg
$15.36
200D Avg
$16.29
Market Cap
$675.59M
Avg Vol (3M)
$433.08K
Beta
0.84
Div Yield
-
SIBN Company Profile
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
SIBN Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-US | $2.09M | $2.26M | $1.97M | $1.80M | $1.81M | $2.07M | $1.88M | $1.89M | $1.96M | $1.67M | $1.47M | $1.45M |
| UNITED STATES | $31.21M | $30.45M | $29.99M | $24.63M | $23.77M | $20.37M | $23.35M | $20.39M | $20.23M | $18.77M | $20.68M | $18.92M |
Fiscal year ends in Dec 24 | Currency in USD